Systemic administration of IL-33 in mice expanded the pool of ST2+ Treg cells and reversed the obesity-induced diminished Treg pool in adipose tissue, resulting in amelioration of hyperinsulinemia and insulin resistance (73). The gene discussed is IL1RL1; the disease is obesity disorder.